Xinjuan Kong

757 total citations
34 papers, 521 citations indexed

About

Xinjuan Kong is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Xinjuan Kong has authored 34 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Xinjuan Kong's work include Hepatitis B Virus Studies (6 papers), MicroRNA in disease regulation (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Xinjuan Kong is often cited by papers focused on Hepatitis B Virus Studies (6 papers), MicroRNA in disease regulation (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Xinjuan Kong collaborates with scholars based in China, United States and United Kingdom. Xinjuan Kong's co-authors include Xue Jing, Ling Gao, Shaoming Li, Keqian Zhi, Zibin Tian, Zhen Sun, Guo Pin, Yanan Yu, Chen Jiang and Xueli Ding and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Xinjuan Kong

28 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinjuan Kong China 11 304 159 98 96 74 34 521
Xinyu Shao China 11 333 1.1× 122 0.8× 179 1.8× 83 0.9× 47 0.6× 29 585
Sophie Van Welden Belgium 9 236 0.8× 77 0.5× 100 1.0× 124 1.3× 40 0.5× 15 530
Yang Xi China 12 401 1.3× 255 1.6× 88 0.9× 44 0.5× 40 0.5× 22 543
Xiaoxin Mu China 12 277 0.9× 136 0.9× 108 1.1× 60 0.6× 42 0.6× 18 469
Haixiang Sun China 14 441 1.5× 251 1.6× 164 1.7× 41 0.4× 63 0.9× 24 705
Chiyi He China 12 201 0.7× 39 0.2× 76 0.8× 65 0.7× 54 0.7× 45 453
Risheng Cao China 13 297 1.0× 206 1.3× 44 0.4× 48 0.5× 47 0.6× 17 498
Shengzheng Luo China 12 229 0.8× 130 0.8× 114 1.2× 119 1.2× 26 0.4× 25 474
Xiangcai Wang China 7 272 0.9× 88 0.6× 109 1.1× 30 0.3× 48 0.6× 29 463

Countries citing papers authored by Xinjuan Kong

Since Specialization
Citations

This map shows the geographic impact of Xinjuan Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinjuan Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinjuan Kong more than expected).

Fields of papers citing papers by Xinjuan Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinjuan Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinjuan Kong. The network helps show where Xinjuan Kong may publish in the future.

Co-authorship network of co-authors of Xinjuan Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Xinjuan Kong. A scholar is included among the top collaborators of Xinjuan Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinjuan Kong. Xinjuan Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rao, Wei, Ye Wang, Bei Zhang, et al.. (2024). Clinical value of [18F]AlF-NOTA-FAPI-04 PET/CT for assessing early-stage liver fibrosis in adult liver transplantation recipients compared with chronic HBV patients. Japanese Journal of Radiology. 42(5). 536–545. 7 indexed citations
2.
Zhang, Qun, et al.. (2022). Both APRI and FIB‐4 could effectively evaluate liver fibrosis in liver transplantation recipients. SHILAP Revista de lepidopterología. 1(3). 197–199. 1 indexed citations
3.
Zhang, Weidong, Jie Guo, Ling Gao, et al.. (2021). Upregulation of mmu_circ_0001066 attenuates the inhibitory effect of bisphosphonates on osteoclastogenesis. Oral Diseases. 28(6). 1591–1602. 4 indexed citations
4.
Gao, Ling, Wenhao Ren, Xiaofei Wang, et al.. (2020). CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways. Experimental Cell Research. 396(2). 112290–112290. 28 indexed citations
6.
Xu, Jian, et al.. (2018). Combination of curcumin and vagus nerve stimulation attenuates cerebral ischemia/reperfusion injury-induced behavioral deficits. Biomedicine & Pharmacotherapy. 103. 614–620. 26 indexed citations
7.
Ren, Wenhao, Ling Gao, Fan Li, et al.. (2017). Circulating high mobility group AT‐hook 2 and pleomorphic adenoma gene 1 in blood of patients with oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 46(10). 998–1003. 6 indexed citations
8.
Gao, Ling, Wenhao Ren, Linmei Zhang, et al.. (2016). PTENp1, a natural sponge of miR‐21, mediates PTEN expression to inhibit the proliferation of oral squamous cell carcinoma. Molecular Carcinogenesis. 56(4). 1322–1334. 72 indexed citations
9.
He, Xingxing, Xinjuan Kong, Junwei Yan, et al.. (2015). CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo. Tumor Biology. 36(3). 1437–1444. 15 indexed citations
11.
Liu, Fang, Xinjuan Kong, Dong Xu, et al.. (2014). Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites. Annals of Hepatology. 13(3). 357–363. 40 indexed citations
13.
Wang, Huihui, Zibin Tian, Xueli Ding, et al.. (2013). Clinical characteristics of hepatic amyloidosis in Chinese patients. World Chinese Journal of Digestology. 21(13). 1261–1261. 1 indexed citations
14.
Liu, Lifeng, Li Jin, Jinjian Yao, et al.. (2011). A Genome-Wide Association Study with DNA Pooling Identifies the Variant rs11866328 in the GRIN2A Gene That Affects Disease Progression of Chronic HBV Infection. Viral Immunology. 24(5). 397–402. 19 indexed citations
15.
Jiang, Yingjun, et al.. (2006). Effects of reasonable pre-operative nutrition on recoveries of gastrointestinal cancer patients. World Chinese Journal of Digestology. 14(19). 1928–1928. 2 indexed citations
16.
Chen, Xiang‐Long, et al.. (2005). Ribozymes against TGFβ1 reverse character of activated hepatic stellate cells in vitro and inhibit liver fibrosis in rats. The Journal of Gene Medicine. 7(7). 965–976. 9 indexed citations
17.
Kong, Xinjuan, Ju‐Sheng Lin, Yuhu Song, Xia Shen, & Youxin Jin. (2003). [Inhibition of mutant p53 in hepatocellular carcinoma cells by hammerhead ribozyme].. PubMed. 11(12). 722–4. 1 indexed citations
18.
Kong, Xinjuan. (2003). Maxizyme-mediated specific inhibition on mutant-type p53in vitro. World Journal of Gastroenterology. 9(7). 1571–1571. 1 indexed citations
19.
Song, Yuhu, et al.. (2003). Effect of specific nucleotide G 11 on cleavage activity of hairpin ribozymes in vitro *. Progress in Natural Science Materials International. 13(5). 345–349.
20.
Lin, Ju‐Sheng, et al.. (2002). [Development of lamivudine-resistance microarray and its reliability in clinical examination].. PubMed. 10(6). 468–468. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026